Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ceglarek

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|March 10, 2001
[Chronic eosinophilic leukemia]I Kredzielak-Manikowska, Z Traczyk, B Ceglarek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Leukemia|October 6, 2001
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemiaT Robak, J Z Błoński, M Kasznicki, et al.
Blood|October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trialT Robak, J Z Bloński, M Kasznicki, et al.
British Journal of Haematology|February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsT Robak, J Z Bloński, M Kasznicki, et al.
Leukemia & Lymphoma|June 1, 1997
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphomaT Róbak, J Gora-Tybor, E Krykowski, et al.
Leukemia & Lymphoma|August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemiaT Robak, M Błasinka-Morawiec, E Krykowski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Polskie Archiwum Medycyny Wewnetrznej|March 10, 2001
[Chronic eosinophilic leukemia]I Kredzielak-Manikowska, Z Traczyk, B Ceglarek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Leukemia|October 6, 2001
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemiaT Robak, J Z Błoński, M Kasznicki, et al.
Blood|October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trialT Robak, J Z Bloński, M Kasznicki, et al.
British Journal of Haematology|February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsT Robak, J Z Bloński, M Kasznicki, et al.
Leukemia & Lymphoma|June 1, 1997
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphomaT Róbak, J Gora-Tybor, E Krykowski, et al.
Leukemia & Lymphoma|August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemiaT Robak, M Błasinka-Morawiec, E Krykowski, et al.
Pageof 1